KOCH KEVIN Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$1.22M

Insider Activity of KOCH KEVIN

According to the SEC Form 4 filings, KOCH KEVIN, being in a position of

  1. President and CEO at Edgewise Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 17971 share for $785,042,
    over all time since 2023-05-02, has bought 0 shares, and sold 46210 shares for $1.34M.

Biography of KOCH KEVIN

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $785,0421100

Comparison of Insiders on Amount of Buys and Sells

2026-08-12SaleEdgewise Therapeutics, Inc.
EWTX
President and CEO
17,971
0.0168%
$43.68$785,042-5.23%
2025-08-12SaleEdgewise Therapeutics, Inc.
EWTX
President and CEO
7,972
0.0078%
$13.39$106,764+118.37%
2025-05-02SaleEdgewise Therapeutics, Inc.
EWTX
President and CEO
4,276
0.004%
$16.45$70,358+1.27%
2025-03-07SaleEdgewise Therapeutics, Inc.
EWTX
President and CEO
100
0.0001%
$30.00$3,000-44.82%
2025-02-06SaleEdgewise Therapeutics, Inc.
EWTX
President and CEO
900
0.001%
$31.13$28,018-46.11%
2025-02-05SaleEdgewise Therapeutics, Inc.
EWTX
President and CEO
8,636
0.0093%
$30.03$259,298-48.52%
2024-05-02SaleEdgewise Therapeutics, Inc.
EWTX
President and CEO
3,152
0.0033%
$18.91$59,604+22.94%
2023-05-02SaleEdgewise Therapeutics, Inc.
EWTX
President and CEO
3,203
0.0052%
$8.90$28,522-7.66%
2007-02-05SaleArray Technologies, Inc.
ARRY
President & CSO
20,000
0.0276%
$14.05$281,100
2007-01-19SaleArray Technologies, Inc.
ARRY
President & CSO
26,900
0.0369%
$14.00$376,600
2006-02-17SaleArray Technologies, Inc.
ARRY
President & CSO
20,000
0.0184%
$9.38$187,680
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.